1. Catalogs
  2. Dynabyte GmbH
  3. ClotPro product brochure

ClotPro product brochure

ClotPro product brochure

ClotPro product brochure

Product catalog summary
Overview: ClotPro is a viscoelastic testing device designed for comprehensive monitoring of hemostasis, particularly useful in managing acute blood coagulation disorders in various medical fields such as surgery and intensive care.
Key Features:
  • Powerful: Offers extensive options for differentiating whole blood coagulation with excellent correlation to conventional viscoelastometry.
  • Efficient: Allows for selective assay performance, parallel testing of multiple samples, and rapid results within 3 minutes.
  • User-Friendly: Features active tip technology to eliminate reagent handling, an intuitive interface, and connectivity options for remote viewing and result transfer.
Specifications:
  • Test Channels: 6
  • Tests: EX-test, IN-test, FIB-test, AP-test, HI-test, RVV-test, ECA-test, TPA-test, NA-test
  • Dimensions: 48cm x 20cm x 8cm
  • Sample Volume: 340 µl citrated blood per test
Technological Innovations:
  • Active-Tip Technology: Utilizes pipette tips containing dry reagents, simplifying the process by automatically adding reagents during sample pipetting.
  • Assays: Includes RVV-test, ECA-test, and TPA-test, each designed for specific coagulation assessments and therapeutic advancements.
Clinical Applications: ClotPro is applicable in cardiac and vascular surgery, organ transplantation, trauma, obstetrics, orthopedic surgery, and intensive care. It supports guidelines from various medical societies for managing bleeding and coagulopathy.
Design and Usability: The device is compact and easy to use, featuring a touch screen, barcode scanner, and multiple input options. It supports up to 6 assays simultaneously, allowing for flexible and efficient diagnostic workups.
Conclusion: ClotPro represents a new generation of viscoelastometry with its robust, precise, and user-friendly design, making it a smart choice for targeted management of coagulopathy.
Performance and Efficiency: ClotPro provides comprehensive options for differentiating whole blood coagulation and shows excellent correlation with conventional viscoelastometry. It allows for parallel testing of multiple samples with a high throughput of six channels, delivering rapid results in under three minutes.
Applications and Benefits: ClotPro supports the management of acute blood coagulation disorders, aiding in the selection of appropriate therapies to stop bleeding. It is beneficial in various medical fields such as cardiac and vascular surgery, organ transplantation, trauma, obstetrics, orthopedic surgery, and intensive care.
Guideline Support: ClotPro's use is supported by several guidelines, including those from the European Society of Anaesthesiology and the American Society of Anesthesiologists, highlighting its role in managing major bleeding and coagulopathy.
Capabilities: ClotPro enables the detection and assessment of factor deficiencies, low fibrinogen, platelet contribution, heparin and DOAC effects, fibrinolysis, and antifibrinolytic drugs, providing rapid and efficient hemostasis monitoring.
See more

Catalog excerpts

ClotPro product brochure-1

COMPREHENSIVE MONITORING OF HEMOSTASIS ClotPro supports the management of acute blood coagulation disorders to facilitate the selection of the most appropriate therapy and stop bleeding. ClotPro enables the detection and assessment of factor deficiencies, low fibrinogen, platelet contribution (to whole blood coagulation), heparin and DOAC effects, fibrinolysis and antifibrinolytic drugs. The benefits of viscoelastic coagulation monitoring have been described in many fields of surgery and intensive care: Cardiac and vascular surgery, organ transplantation, trauma, obstetrics, orthopaedic surgery and intensive care. Guideline support for use of viscoelastic testing (examples): The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016:12;20:100. From blood transfusion to patient blood management: a new paradigm for patient care and cost assessment of blood transfusion practice. Internal medicine journal, 2012. 42(3), 332-338. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management. Anesthesiology. 2015;122(2):241-75 Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. European Journal of Anaesthesiology (EJA) 34.6 (2017): 332-395. +++ targeted management of coagulopathy +++ THE SMART CHOICE FOR VISCOELASTIC TESTING Clotpro is powerful ∙ Most comprehensive options for the differentiation of whole blood coagulation Excellent correlation with conventional viscoelastometry Test channels EX-test, IN-test, FIB-test, AP-test, HI-test, RVV-test, ECA-test, TPA-test, NA-test Dimensions (instrument) Sample volume 340 µl citrated blood per test Perform (and pay) only the assays you require Parallel testing of multiple samples Best in class throughput (6 channels) Very fast (< 3 min for first results (CT)) Active tip technology eliminates the need for reagent handling Intuitive user interface Remote viewing of test results Transfer of test results via email © 2020 enicor GmbH. All rights reserved. All trademarks mentioned enjoy legal protection. REV002_EN – 2020-01 enicor GmbH Reichenbach Str 27 80469 Munich Germany [email protected] www.clot.pro +++ powerful +++ efficient +++ user-friendly +++

 Open the catalog to page 1
ClotPro product brochure-2

COMPREHENSIVE MONITORING OF HEMOSTASIS ClotPro supports the management of acute blood coagulation disorders to facilitate the selection of the most appropriate therapy and stop bleeding. ClotPro enables the detection and assessment of factor deficiencies, low fibrinogen, platelet contribution (to whole blood coagulation), heparin and DOAC effects, fibrinolysis and antifibrinolytic drugs. The benefits of viscoelastic coagulation monitoring have been described in many fields of surgery and intensive care: Cardiac and vascular surgery, organ transplantation, trauma, obstetrics, orthopaedic surgery and...

 Open the catalog to page 2
ClotPro product brochure-3

CUTTING-EDGE ASSAYS AND DRY CHEMISTRY TECHNOLOGY ACTIVE-TIP TECHNOLOGY: The pipette-tip contains test specific dry reagents. All reagent handling is eliminated. Rapid overview of the coagulation process Detection of functional fibrinogen under dual platelet inhibition Inhibition of fibrinolysis facilitating the detection of hyperfibrinolytic activity (in combination with EX-test) Intrinsic screening test, sensitive to heparin and coagulation factors e.g. FVIII IN-test with heparin neutralisation to ascertain residual coagulation activity Activation of fibrinolysis for the detection of antifibrinolytic...

 Open the catalog to page 3
ClotPro product brochure-4

CUTTING-EDGE ASSAYS AND DRY CHEMISTRY TECHNOLOGY ACTIVE-TIP TECHNOLOGY: The pipette-tip contains test specific dry reagents. All reagent handling is eliminated. Rapid overview of the coagulation process Detection of functional fibrinogen under dual platelet inhibition Inhibition of fibrinolysis facilitating the detection of hyperfibrinolytic activity (in combination with EX-test) Intrinsic screening test, sensitive to heparin and coagulation factors e.g. FVIII IN-test with heparin neutralisation to ascertain residual coagulation activity Activation of fibrinolysis for the detection of antifibrinolytic...

 Open the catalog to page 4
ClotPro product brochure-5

CUTTING-EDGE ASSAYS AND DRY CHEMISTRY TECHNOLOGY ACTIVE-TIP TECHNOLOGY: The pipette-tip contains test specific dry reagents. All reagent handling is eliminated. Rapid overview of the coagulation process Detection of functional fibrinogen under dual platelet inhibition Inhibition of fibrinolysis facilitating the detection of hyperfibrinolytic activity (in combination with EX-test) Intrinsic screening test, sensitive to heparin and coagulation factors e.g. FVIII IN-test with heparin neutralisation to ascertain residual coagulation activity Activation of fibrinolysis for the detection of antifibrinolytic...

 Open the catalog to page 5
ClotPro product brochure-6

COMPREHENSIVE MONITORING OF HEMOSTASIS ClotPro supports the management of acute blood coagulation disorders to facilitate the selection of the most appropriate therapy and stop bleeding. ClotPro enables the detection and assessment of factor deficiencies, low fibrinogen, platelet contribution (to whole blood coagulation), heparin and DOAC effects, fibrinolysis and antifibrinolytic drugs. The benefits of viscoelastic coagulation monitoring have been described in many fields of surgery and intensive care: Cardiac and vascular surgery, organ transplantation, trauma, obstetrics, orthopaedic surgery and...

 Open the catalog to page 6
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.